In this video, Dr. Douglas L. Packer of the Mayo Clinic provides details about the landmark CABANA Trial comparing Catheter Ablation to Antiarrhythmic Drugs for Atrial Fibrillation. Dr. Packer is the Lead Investigator for the CABANA Trial. View the video: Dr. Packer Explains the CABANA Trial of Catheter Ablation vs. Drugs About Douglas L. Packer, MD: …
Read More
November 29, 2010 — StopAfib.org is proud to announce its participation in the Facing AFib™ program with Boehringer Ingelheim Pharmaceuticals, Inc., National Stroke Association, and Susan Lucci and her husband Helmut Huber. Facing AFib is a nationwide, multimedia campaign designed to educate Americans about atrial fibrillation (afib) and to encourage those with the condition to …
Read More
Dallas, November 22, 2010 — If you're headed out for the holidays, here's why you should opt out of the full-body scanners at the airport, especially if you're an atrial fibrillation patient or have other heart arrhythmias or heart disease. Please share this story with family and friends as these machines are a health disaster …
Read More
CHICAGO, Nov. 15, 2010 – A new anti-clotting drug is as effective as the standard medication in preventing stroke and blood clots, and does not increase bleeding risk among patients with the most common form of irregular heartbeat, atrial fibrillation, according to late-breaking randomized, double-blind clinical trial results presented at the American Heart Association’s Scientific …
Read More
By Mellanie True Hills The atrial fibrillation patient community is invited to try myLifeLog, an application for tracking afib experiences. Here's some background. One of my wishes has been for the afib community to have a way to capture information that can help us identify trends and help us get a handle on this condition. Some …
Read More
By Mellanie True Hills November 9, 2010 — StopAfib.org would like to let you know about some new content and updated information. New atrial fibrillation patient profile — Our newest patient profile is of Jason Mattingly, a young father of three who is now afib free as a result of catheter ablations. Check out all our patient profiles while …
Read More
The European Society of Cardiology’s Guidelines for the Management of Atrial Fibrillation offer recommendations for patient care and treatment in a wide variety of scenarios. So if you have unusual circumstances, you may find important answers here. Since the American Heart Association, American College of Cardiology, and European Society of Cardiology last released their joint atrial …
Read More
By Christine Welniak and Mellanie True Hills November 1, 2010 — New medical guidelines from the European Society of Cardiology (ESC) incorporating the latest research put Europe ahead of the US when it comes to standardized treatment of atrial fibrillation. The previous guidelines, which were a cooperative endeavor between multiple European and American medical societies …
Read More
By Mellanie True Hills October 27, 2010—On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. …
Read More
By Mellanie True Hills October 19, 2010 — The day the afib community has awaited has finally arrived — the FDA has just approved Pradaxa (dabigatran), the first alternative to Coumadin (warfarin), for preventing afib-related strokes in those with atrial fibrillation. On September 20, 2010, the FDA's Advisory Committee recommended unanimously that the FDA approve …
Read More